Sun Pharmaceutical Industries Ltd.'s Biologics License Application for tildrakizumab has been accepted by the U.S. Food and Drug Administration.
Read More »
ONEPOINT PATIENT CARE: To Open Hospice-Dedicated Pharmacy in Delaware
CVS PHARMACY: Opens First Standalone Retail Locations in Oregon
SENTRY DATA SYSTEMS: launches pharmacy claims management solution to help reduce denials and improve claims processing